Controlled clinical trials for the development of tolerance and its implications on dosing schedules in nitrate therapy;KONTROLLIERTE KLINISCHE STUDIEN ZUR TOLERANZENTWICKLUNG UND DOSIERUNGSPROBLEME DER NITRATTHERAPIE

Herz

Volumn 21, Issue SUPPL. 1, 1996, Pages 23-30

  Abshagen, U ^a  

^a NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ISOSORBIDE 5 NITRATE; ISOSORBIDE DINITRATE; NITRIC ACID DERIVATIVE;

ANGINA PECTORIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG TOLERANCE; HUMAN; RANDOMIZED CONTROLLED TRIAL; SHORT SURVEY; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0029967097     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (18)

1. Abrams, J.: Fundamentals of clinical cardiology. Nitrate tolerance and dependence. Amer. Heart J. 99 (1980), 113-123.
2. Blasini, R.: Wirkungsverlust von Isosorbiddinitrat bei Langzeitbehandlung der chronischen Herzsinsuffizienz. Herz 7 (1982). 250-258.
3. Blasini, R., U. Bruegmann, A. Mannes, K. L. Frör, D. Hall, W. Rudolph: Wirksamkeit von Isosorbiddinitrat in retardierter Form bei Langzeitbehandlung. Herz 5 (1980), 298-305.
4. Crout, J. R.: Klinische Entwicklung von Isosorbid-5-Mononitrat in den USA. Münch. med. Wschr. 135, Suppl. 1 (1993), 53-57.
5. Danahy, D. T., W. S. Aronow: Hemodynamics and antianginal effects of high dose oral isosorbide dinitrate after chronic use. Circulation 56 (1977), 205-212.
6. DeMots, H., S. P. Glasser on behalf of the Transderm-Nitro Trial Study Group: Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina. J. Amer. Coll. Cardiol. 13 (1989), 786-793.
7. Franciosa, J. A., J. N. Cohn: Sustained hemodynamic effects without tolerance during long-term isosorbide dinitrate treatment of chronic left ventricular failure. Amer. J. Cardiol. 45 (1980), 648-654.
8. Needleman, P , E. M. Johnson: Mechanism of tolerance development to organic nitrates. J. Pharmacol. exp. Ther. 184 (1973), 709-715.
9. Needleman, P., et al.: Sulfhydryl requirement for relaxation of vascular smooth muscle. J. Pharmacol. exp. Ther. 187 (1973), 324-331.
10. Poorvin, D. on behalf of the Steering Committee: Transdermal Nitroglycerin Cooperative Study. Amer. J. Cardiol. 68 (1991), 1263-1273.
11. Reiniger, G., R. Blasini, U. Bruegmann, W. Rudolph: Toleranz-entwicklung hinsichtlich der antiischämischen Wirkung von Isosorbiddmitrat bei regelmäßiger, mehrfach täglicher Verabreichung. Herz 9 (1984), 146-152.
12. Rudolph, W., R. Blasini, G. Reiniger, U. Brügmann: Tolerance development during isosorbide dinitrate treatment: Can it be circumvented? Z. Kardiol. 72, Suppl. 3 (1983), 195-198.
13. Rudolph, W., J. Dirschinger, G. Reiniger, A. Beyerle, D. Hall: When does nitrate tolerance develop? What dosages and which intervals are necessary to ensure maintained effectiveness? Europ. Heart J. 9, Suppl. A (1988), 63-72.
14. Silber, S., A. C. Vogler, K. H. Krause, M. Vogel, K. Theisen: Induction and circumvention of nitrate tolerance applying different dosage intervals. Amer. J. Med. 83 (1987), 860-870.
15. Silber, S., K. H. Krause, C. Garner, K. Theisen, H. Jahrmärker: Anti-ischemic effects of an 80 mg tablet of isosorbide dinitrate in sustained release form before and after 2 weeks treatment with 80 mg once-daily or twice-daily. Z. Kardiol. 72, Suppl. 3 (1983), 211-217.
16. Stewart, D. D.: Tolerance to nitroglycerin. J. Amer. med. Ass. 44 (1905), 1678-1679.
17. Thadani, U., H. L. Fung, A. C. Darke, J. O. Parker: Oral Isosorbide dinitrate in the treatment of angina pectoris. Dose-response relationship and duration of action during acute therapy. Circulation 62 (1980), 491-502.
18. Thadani, U., C. R. Maranda, E. Amsterdam, L. Spaccavento, R. G. Friedmann, R. Chernoff, S. Zellner, J. Gorwitt, P. H. Hinderaker: Lack of pharmacologic tolerance and rebound angina pectoris during twice-daily therapy with isosorbide-5-mononitrate. Ann. intern. Med 120 (1994), 353-359.